Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director

Nurix Therapeutics, Inc. (NRIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Third Rock Ventures III, L.P. reports a 0.4% stake in Nurix Therapeutics, Inc.
02/14/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 10% stake in Nurix Therapeutics, Inc.
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 6.9% stake in NURIX THERAPEUTICS INC
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/25/2023 SC 13G/A BlackRock Inc. reports a 8.8% stake in Nurix Therapeutics, Inc.
02/14/2022 SC 13G/A Redmile Group, LLC reports a 6.6% stake in Nurix therapeutics, Inc.
02/14/2022 SC 13G/A Third Rock Ventures III, L.P. reports a 5.7% stake in Nurix Therapeutics, Inc.
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 10.9% stake in Nurix Therapeutics, Inc.
02/11/2022 SC 13G/A COLUMN GROUP L P reports a 1.5% stake in NURIX THERAPEUTICS, INC.
02/11/2022 SC 13G/A Foresite Capital Fund IV, L.P. reports a 2.7% stake in Nurix Therapeutics, Inc.
02/04/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Foresite Capital Fund IV, L.P. reports a 8.4% stake in Nurix Therapeutics, Inc.
02/04/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy